• Bone Health
  • Immunology
  • Hematology
  • Respiratory
  • Dermatology
  • Diabetes
  • Gastroenterology
  • Neurology
  • Oncology
  • Ophthalmology
  • Rare Disease
  • Rheumatology

Biosimilars Poll: What are the characteristics of a healthy biologics marketplace?


Opposing interests make it hard to define what elements are essential for a competitive marketplace.

Take the Biosimilars Poll!

Person voting with a ballot box

As a recent report from Amgen made clear, biosimilars are gaining ground in the biologics marketplace, but across drug categories the pace of this advance is highly uneven.

Which of these is most characteristic of a healthy biologics marketplace?

Innovator companies develop new products that capture share from biosimilars.
Reference product prices decline to match biosimilar discounts.
Regulators establish policies to favor biosimilar use.

Check out the results from our last poll:

Infographic with a pie chart of the responses from our last poll

Click to enlarge

© 2024 MJH Life Sciences

All rights reserved.